SCYX FY 2018 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$257,000+0.0% YoY

Gross Profit

$257,000100.0% margin

Operating Income

-$30M-11666.5% margin

Net Income

-$12M-4851.4% margin

EPS (Diluted)

$-2.84

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$53M

Total Liabilities

$22M

Stockholders' Equity

$31M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$257,000	$257,000	+0.0%
Gross Profit	$257,000	$257,000	+0.0%
Operating Income	-$30M	-$26M	-13.9%
Net Income	-$12M	-$25M	+50.2%